LSX World Congress

LSX World Congress formerly known as Biotech and Money Congress
133 Houndsditch | Liverpool St | London
4-5 February, 2020
 

Meet our early 2020 confirmed speakers
Sergio Capancioni, Director Search & Evaluation Western Europe, AbbVie

Sergio Capancioni

Director Search & Evaluation Western Europe
AbbVie
Richard di Benedetto, President, Aetna International

Richard di Benedetto

President
Aetna International
Yochi Slonim, Co-Founder & CEO, Anima Biotech Inc

Yochi Slonim

Co-Founder & CEO
Anima Biotech Inc
Mark Altmeyer, CEO, Arvelle Therapeutics

Mark Altmeyer

CEO
Arvelle Therapeutics
Jordi Naval, CEO, Biocat

Jordi Naval

CEO
Biocat
Eline Vrijland-Van Beest, Partner, Blue Sparrows MedTech Fund

Eline Vrijland-Van Beest

Partner
Blue Sparrows MedTech Fund
Jonathan Goldstein, Partner, Boston Scientific

Jonathan Goldstein

Partner
Boston Scientific
Johnston Erwin, VP Corporate Business Development, Eli Lilly

Johnston Erwin

VP Corporate Business Development
Eli Lilly
Renée Aguiar-Lucander, CEO, Calliditas

Renee Aguiar-Lucander

CEO
Calliditas Therapeutics
Martin Frost, CEO, CMR Surgical

Martin Frost

CEO
CMR Surgical
Mirko Scherer, CEO, CoFeS China Ltd

Mirko Scherer

CEO
CoFeS China Ltd
Tim Luker, Senior Director External Innovation, Eli Lilly

Tim Luker

Senior Director External Innovation
Eli Lilly
Pierre Belichard, CEO, Enterome Bioscience

Pierre Belichard

CEO
Enterome Bioscience
Bernard Ross, CEO & Founder, First Kind Medical

Bernard Ross

CEO & Founder
First Kind Medical
Sander Slootweg, Managing Partner, Forbion

Sander Slootweg

Managing Partner
Forbion
Dan Zhang, Executive Chairman, Fountain Medical Development

Dan Zhang

Executive Chairman
Fountain Medical Development
Onno Van de Stolpe, CEO, Galapagos

Onno Van de Stolpe

CEO
Galapagos
Mathias Goyen, CMO Europe, GE Healthcare

Mathias Goyen

CMO Europe
GE Healthcare
Ingrid Akay, Managing Partner, Hadean Ventures

Ingrid Akay

Managing Partner
Hadean Ventures
Martin Pfister, Senior Investment Manager, High-Tech Gründerfonds

Martin Pfister

Senior Investment Manager
High-Tech Gründerfonds
Patrik Sobocki, Investor, Industrifonden

Patrik Sobocki

Investor
Industrifonden
Roel Bulthuis, Managing Director, Inkef Capital

Roel Bulthuis

Managing Director
Inkef Capital
Ivana Magovčević-Liebisch, CBO, Ipsen

Ivana Magovčević-Liebisch

CBO
Ipsen
Jan Keltjens, Chairman of the Board of Directors, JenaValve

Jan Keltjens

Chairman of the Board of Directors
JenaValve
Zishan Haroon, Chairman & General Partner, Julz Co LLC

Zishan Haroon

Chairman & General Partner
Julz Co LLC
David Tuch, CEO, Lightpoint Medical

David Tuch

CEO
Lightpoint Medical
Caroline Gaynor, Vice President, Lightstone Ventures

Caroline Gaynor

Vice President
Lightstone Ventures
Hakan Goker, Senior Investment Director, M Ventures

Hakan Goker

Senior Investment Director
M Ventures
Søren Bregenholt, CEO, Macrophage

Søren Bregenholt

CEO
Macrophage
Giovanni Mariggi, Partner, Medicxi

Giovanni Mariggi

Partner
Medicxi
Lifei Cheng, Founder & CEO, MedTecx

Lifei Cheng

Founder & CEO
MedTecx
Maarten Akkerman, VP Medical Affairs & Value-Based Healthcare EMEA, Medtronic

Maarten Akkerman

VP Medical Affairs & Value-Based Healthcare EMEA
Medtronic
Charity Kufaas, VP BD, Medtronic

Charity Kufaas

VP BD
Medtronic
Phil L’Hullier, Head of BD, Europe, European Innovation Hub, MSD

Phil L’Hullier

Head of BD, Europe, European Innovation Hub
MSD
David Germonpré, Investment Partner, MTIP

David Germonpré

Investment Partner
MTIP
Thomas Lönngren, Former Head of EMA & Advisor, NDA

Thomas Lönngren

Former Head of EMA & Advisor
NDA
Bibhash Mukhopadhyay, Principal, New Enterprise Associates

Bibhash Mukhopadhyay

Principal
New Enterprise Associates
Miriam Frieden, VP Search & Evaluation, Novo Nordisk

Miriam Frieden

VP Search & Evaluation
Novo Nordisk
Vanessa Vankerckhoven, CEO & Co-Founder, Novosanis NV

Vanessa Vankerckhoven

CEO & Co-Founder
Novosanis NV
Nissim Darvish, Senior Managing Director, OrbiMed

Nissim Darvish

Senior Managing Director
OrbiMed
Katherine Cohen, Venture Partner, Panacea Ventures

Katherine Cohen

Venture Partner
Panacea Ventures
Alessio Beverina, Managing Partner, Panakes Partners

Alessio Beverina

Managing Partner
Panakes Partners
Ulrich Zuegel, Senior Director Emerging Science & Innovation Lead, Pfizer

Ulrich Zuegel

Senior Director Emerging Science & Innovation Lead
Pfizer
Luc Dochez, Managing Director, PrimixBioVentures

Luc Dochez

Managing Director
PrimixBioVentures
John E Milad, CEO, Quanta Dialysis

John E Milad

CEO
Quanta Dialysis
Seamus Browne, Head of Industry Partnerships, Royal College of Surgeons

Seamus Browne

Head of Industry Partnerships
Royal College of Surgeons
Olav Hellebo, CEO, ReNeuron Group

Olav Hellebo

CEO
ReNeuron Group
Vivek Ramaswamy, CEO, Roivant Sciences

Vivek Ramaswamy

CEO
Roivant Sciences
Don deBethizy, Chair of Board, Saniona AB

Don deBethizy

Chair of Board
Saniona AB
Laia Crespo, Head of Europe, Sanofi Ventures

Laia Crespo

Head of Europe
Sanofi Ventures
Ian Crosbie, CEO, Sequana Medical AG

Ian Crosbie

CEO
Sequana Medical AG
Daniel O’Mahony, Partner, Seroba Life Sciences

Daniel O’Mahony

Partner
Seroba Life Sciences
Sascha Alilovic, Partner, SHS Capital

Sascha Alilovic

Partner
SHS Capital
David Horn Solomon, CEO, Silence Therapeutics

David Horn Solomon

CEO
Silence Therapeutics
Graziano Seghezzi, Managing Partner, Sofinnova Partners

Graziano Seghezzi

Managing Partner
Sofinnova Partners
Deborah Harland, Partner, SR One

Deborah Harland

Partner
SR One
Mattias Haeggblom, Portfolio Manager, Swedbank Robur

Mattias Haeggblom

Portfolio Manager
Swedbank Robur
Chas Taylor, CEO & Executive Director, Veryan Medical

Chas Taylor

CEO & Executive Director
Veryan Medical
Dave Madge, VP of the Research Service Division, WuXi AppTec

Dave Madge

VP of the Research Service Division
WuXi AppTec
Susana de Azevedo Wäsch, VP Quality Management & Regulatory Affairs, Ypsomed AG

Susana de Azevedo Wäsch

VP Quality Management & Regulatory Affairs
Ypsomed AG
Steve Atkinson, CEO, Atlantic Healthcare

Steve Atkinson

CEO
Atlantic Healthcare
James Pink, Executive Vice President - Consulting, NSF Health Sciences Ltd

James Pink

Executive Vice President - Consulting
NSF Health Sciences Ltd
Arnd Kaltofen, General Partner, VI Partners

Arnd Kaltofen

General Partner
VI Partners
Jack Nielsen, MD, Vivo Capital

Jack Nielsen

MD
Vivo Capital
Jens Hennecke, CBO, Sotio AS

Jens Hennecke

CBO
Sotio AS
Sara Secall, Investment Director & Partner, Inveready Asset Management

Sara Secall

Investment Director & Partner
Inveready Asset Management
Kyparissia Sirinakis, Managing Partner, Epidarex

Kyparissia Sirinakis

Managing Partner
Epidarex
Michael Altorfer, CEO, SwissBiotech

Michael Altorfer

CEO
SwissBiotech
Leon Lerman, CEO & Co-Founder, Cynerio

Leon Lerman

CEO & Co-Founder
Cynerio
Sean Marett, CBO, CCO, BioNTech AG

Sean Marett

CBO, CCO
BioNTech AG
Mark Jan Harte, Co-Founder & CEO, Aidence

Mark Jan Harte

Co-Founder & CEO
Aidence
ENQUIRE HERE

Never miss an update

Sign up to event updates to hear about new speakers, promotions, conference news and networking events.

ABOUT US

LSX is an influential community of senior life science decision makers. We connect senior life science executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.

 
EVENTS

Digihealth Leaders

Inv€$tival Showcase

Lifestars Awards

LSX World Congress

Longevity Leaders Conference

LSX Nordic Congress

LSX World Congress USA

 
LINKS

About

Partners

FAQs

Resources

Contact Us


© 2019 All Rights Reserved By LSX Ltd | Privacy Policy